银华中证创新药产业ETF发起式联接C(012782)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
115,792,000 |
109,983,000 |
132,244,000 |
138,053,000 |
-5,809,000 |
-5.02% |
2023/12/31 |
6,845,290 |
115,792,000 |
314,005,000 |
205,058,000 |
108,947,000 |
1591.56% |
2023/12/31 |
94,864,400 |
115,792,000 |
140,798,000 |
119,871,000 |
20,927,000 |
22.06% |
2023/9/30 |
65,002,300 |
94,864,400 |
75,451,800 |
45,589,600 |
29,862,200 |
45.94% |
2023/6/30 |
6,845,290 |
65,002,300 |
97,754,600 |
39,597,700 |
58,156,900 |
849.59% |
2023/6/30 |
11,772,200 |
65,002,300 |
86,910,600 |
33,680,600 |
53,230,000 |
452.17% |
2023/3/31 |
6,845,290 |
11,772,200 |
10,844,000 |
5,917,100 |
4,926,900 |
71.98% |
2022/12/31 |
2,219,950 |
6,845,290 |
28,388,000 |
23,762,600 |
4,625,400 |
208.36% |
2022/12/31 |
5,277,490 |
6,845,290 |
11,952,700 |
10,384,900 |
1,567,800 |
29.71% |
2022/9/30 |
3,656,560 |
5,277,490 |
9,687,400 |
8,066,480 |
1,620,920 |
44.33% |
2022/6/30 |
2,219,950 |
3,656,560 |
6,747,900 |
5,311,290 |
1,436,610 |
64.71% |
2022/6/30 |
4,018,170 |
3,656,560 |
3,489,120 |
3,850,730 |
-361,610 |
-9% |
2022/3/31 |
2,219,950 |
4,018,170 |
3,258,780 |
1,460,560 |
1,798,220 |
81% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。